References
- MenkenMMunsatTTooleJThe Global Burden of Disease Study: implications for neurologyArch Neurol20005741842010714674
- WHOThe global burden of disease: 2004 updateWHO2008 Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.htmlAccessed March 1, 2016
- JauchECucchiaraBAdeoyeOPart 11: Adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareCirculation2010122s818s82820956227
- HackeWDonnanGFieschiCAssociation of outcome with early stroke treatment: pooled analysis of ATLANT, ECASS, and NINDS rt-PA stroke trialsLancet200436376877415016487
- LeesKBluhmkiEvon KummerRTime to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHETLancet20103751695170320472172
- O’RourkeKWalshCKellyPSafety and efficacy of IV-TPA for ischaemic stroke in clinical practice – a Bayesian analysisCerebrovasc Dis20092857258119844097
- Tissue plasminogen activator for acute ischemic strokeThe National Institute of Neurological Disorders and Stroke rt-PA Stroke Study GroupN Engl J Med199533324158115877477192
- HosseiniASobhani-RadDGhandehariKFrequency and clinical patterns of stroke in Iran – systematic and critical reviewBMC Neurol2010107220731823
- LopezAMathersCEzzatiMGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet20063671747175716731270
- GhandehariKZahedATaheriMEstimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA (Letter to the editor)Int J Stroke2009423619689746
- SuwanwelaNPhanthumchindaKLikitjaroenYThrombolytic therapy in acute ischemic stroke in Asia: the first prospective evaluationClin Neurol Neurosurg200610854955216289309
- De SilvaDYassinNTohATiming of arrival to a tertiary hospital after acute ischaemic stroke – a follow-up survey 5 years laterAnn Acad Med Singapore20103951351520697668
- NguyenTTruongANgoMPatients with thrombolysed stroke in Vietnam have an excellent outcome: results from the Vietnam Thrombolysis RegistryEur J Neurol2010171188119220236303
- PandianDPadmaVVijayaPStroke and thrombolysis in developing countriesInt J Stroke20072172618705983
- BryerAWassermanSThrombolysis for acute ischemic stroke in South AfricaInt J Stroke2013811211323692573
- NæssHWaje-AndreassenUBrøggerJPatients with acute cerebral infarction admitted to stroke unit (abstract)Tidsskr Nor Laegeforen2011131814818 Norwegian [with English abstract]21556084
- WasayMBarohiHMalikAUtilization and outcome of thrombolytic therapy for acute stroke in PakistanNeurol Sci20103122322519816656
- MeretojaARoineROKasteMEffectiveness of primary and comprehensive stroke centers: PERFECT stroke: a nationwide observational study from FinlandStroke2010411102110720395609
- SharmaVKTsivgoulisGTanJHFeasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in SingaporeJ Stroke Cerebrovasc Dis201019642443020554224
- AyromlouHSoleimanpourHFarhoudiMEligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementationIran Red Crescent Med J2014165e1128425031844
- AzarpazhoohMREtemadiMMDonnanGAExcessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle EastStroke2010411e3e1019926844
- MehrpourMAghaeiMMotamedMSafety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic strokeMed J Islam Repub Iran201327311311824791120
- Statistical Center of IranThe results of census 2011 (AD1390): statistical center of Iran2012 Available from: http://www.amar.org.irAccessed March 1, 2016
- AyromlouHSoleimanpourHFarhoudiMWhat are the most important barriers for thrombolytic therapy in ischemic stroke patients?Int J Stroke201384E723692492
- Sadeghi-HokmabadiETaheraghdamAHashemilarMSimple in-hospital interventions to reduce door-to-CT time in acute strokeInt J Vasc Med20162016165621227478641
- CandeliseLPinardiGAritzuETelephone interview for stroke outcome assessmentCerebrovasc Dis19944341343
- The National Institute of Neurological Disorders and StrokeInterventional Management of Stroke III Trial (IMS III): The National Institute of Neurological Disorders and Stroke2012 [cited 2012]. Available from: http://www.ninds.nih.gov/disorders/clinical_trials/IMS-III.htmAccessed March 1, 2016
- BerkhemerOAFransenPSSBeumerDMR CLEAN Investigators. A randomized trial for intraarterial treatment for acute ischemic strokeN Engl J Med2015372112025517348
- PierotLPereiraVMCognardCvon KummerRTeaching lessons by MR CLEANAm J Neuroradiol201536581982125742987
- FurlanAHigashidaRWechslerLIntra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. prolyse in acute cerebral thromboembolismJAMA1999282212003201110591382
- RudolfJTsivgoulisGDeretziGFeasibility and safety of intravenous thrombolysis for acute ischaemic stroke in northern GreeceInt J Stroke201161919221205250
- WahlgrenNAhmedNDavalosAThrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyLancet2007369955827528217258667
- ChiuDKriegerDVillar-CordovaCIntravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practiceStroke199829118229445322
- PashapourAAtaluAFarhoudiMEarly and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke systemPak J Med Sci201329118118624353536
- Guidelines for the early management of patients with acute ischemic stroke: executive summaryAmerican Heart Association/American Stroke Association2014 Available from: http://stroke.ahajournals.org/content/suppl/2013/01/29/STR.0b013e318284056a.DC1/Executive_Summary.pdf
- FonarowGCSmithEESaverJLTimeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutesCirculation201112375075821311083
- FonarowGCSmithEESaverJLImproving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association’s target: stroke initiativeStroke2011422983298921885841
- JauchECSaverJLAdamsHPAmerican Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke201344387094723370205
- WassermanSBryerAEarly outcomes of thrombolysis for acute ischaemic stroke in a South African tertiary care centreS Afr Med J2012102654154422668959
- PadmaMVSinghMBBhatiaRHyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing countryNeurol India2007551464917272899
- MuengtaweepongsaSDharmasarojaPKummarkUOutcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing countryJ Stroke Cerebrovasc Dis2012211424622225863
- SmithEEHassanKAFangJDo all ischemic stroke subtypes benefit from organized inpatient stroke care?Neurology201075545646220592254
- NikkhahKAvanAShoeibiAGaps and hurdles deter against following stroke guidelines for thrombolytic therapy in Iran: exploring the problemJ Stroke Cerebrovasc Dis201524240841525511616